Methanol → 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1H-pyrrolo[2,3-b]pyridine, trifluoroacetate salt
Reaction equation
[C:1]([C:5]1[N:6]([CH3:27])[CH:7]=[C:8]([C:10]2[CH:15]=[CH:14][N:13]=[C:12]3[N:16](OCC[Si](C)(C)C)[C:17](C)=[CH:18][C:11]=23)[N:9]=1)([CH3:4])([CH3:3])[CH3:2].[C:28]([OH:34])([C:30]([F:33])([F:32])[F:31])=[O:29].CO.[NH4+].[OH-]>>[F:31][C:30]([F:33])([F:32])[C:28]([OH:34])=[O:29].[C:1]([C:5]1[N:6]([CH3:27])[CH:7]=[C:8]([C:10]2[CH:15]=[CH:14][N:13]=[C:12]3[NH:16][CH:17]=[CH:18][C:11]=23)[N:9]=1)([CH3:4])([CH3:2])[CH3:3]Participants
5
Procedure
A solution of 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1-[2-(trimethylsilyl)-ethoxy]-methyl-1H-pyrrolo[2,3-b]pyridine (0.010 g, 0.000026 mol) in TFA (3 mL, 0.04 mol) was stirred for 2 hours. Then the excess TFA was evaporated and the residue was stirred in methanol (3 mL, 0.07 mol) and NH4OH (1 mL) for 16 hours. The solvents were removed and the product was purified by preparative-HPLC (C18 eluting with a gradient of ACN/H2O containing 0.1% TFA) to afford 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1H-pyrrolo[2,3-b]pyridine, trifluoroacetate salt (9 mg, 90%).
Workup
- customThen the excess TFA was evaporated
- customThe solvents were removed
- customthe product was purified by preparative-HPLC (
- washC18 eluting with a gradient of ACN/H2O containing 0.1% TFA)
Sources & evidence
- ORD record
- ord-24c7787e041648cf96ce03346e904bc3
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08541425B2
Reaction notes
Loading…